A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ocular Hypertension
Related studies linked through entity extraction aliases.
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
- Status
- COMPLETED
- Phase
- PHASE2
Use of an Ocular Telemetry Sensor in Diamox Treated Patients
- Status
- COMPLETED
- Phase
- NA
Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of a Drug Delivery System in Glaucoma
- Status
- COMPLETED
- Phase
- PHASE2
Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution
- Status
- COMPLETED
- Phase
- PHASE2
Tolerance and Effect on Intraocular Pressure After Administration of SYL040012
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Tolerability of Xalatan in Patients
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure
- Status
- COMPLETED
- Phase
- PHASE4
Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination
- Status
- COMPLETED
- Phase
- PHASE4
A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation
- Status
- COMPLETED
- Phase
- PHASE3
DuoTrav APS Versus XALACOM® in Ocular Surface Health
- Status
- TERMINATED
- Phase
- PHASE3
Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health
- Status
- COMPLETED
- Phase
- PHASE3